Healthcare Cost Disparities: A Deepening Crisis in the United States

A recent survey by the Commonwealth Fund is downright embarrassing. Compared to nine other high-income countries, the U.S. stands alone in its wide disparity in healthcare access, both within the country between lower and higher-income individuals and also between high-income people in other countries. 

Share This Post

A recent survey by the Commonwealth Fund is downright embarrassing. Compared to nine other high-income countries, the U.S. stands alone in its wide disparity in healthcare access, both within the country between lower and higher-income individuals and also between high-income people in other countries. 

The Commonwealth Fund surveyed adults in nine countries with high GDPs, including Australia, Canada, France, Germany, New Zealand, Netherlands, Switzerland, the U.K., and the U.S. The results are disturbing. According to the survey,

  • Adults in the U.S. with low to average incomes are more likely to skip needed medical care and have problems paying medical bills than all other countries in the analysis.
  • In the U.S., adults with higher incomes are more likely to have healthcare affordability problems, including cost-related access issues and medical bill problems, than their counterparts in most other countries.

Cost-related barriers to healthcare set the United States far apart from its peer nations. A staggering 46% of surveyed U.S. adults with average or lower incomes reported forgoing medical care in the past 12 months due to financial constraints. This figure surpasses other affluent countries, with New Zealand trailing behind at 34%. The rates reported in the U.K., Netherlands, Germany, and France were substantially lower, emphasizing the issue’s magnitude within the U.S.

Figure I: Percent of adults who skip or delay getting needed health care due to cost.

Source: Commonwealth Fund 2023 International Health Policy Survey

The disparities in healthcare access extend beyond medical care alone. The survey highlights significant income-related gaps in the United States’ dental and mental healthcare access. Regarding dental care, 46% of low or average-income Americans reported skipping treatments due to costs, more than double that higher-earning populations reported (24%). The income divide in mental healthcare access showed a similar picture. Twenty-one percent of low or average-income individuals avoided mental healthcare services due to costs compared to 14% among higher-income respondents.

As the survey clearly reveals, average Americans are struggling with healthcare disparities, and there is an urgent need to alleviate the burden of exorbitant drug costs.

The critical focal point for RazorMetrics is directly engaging physicians to prescribe the most affordable medication for their patients and our clients’ members/employees. No other drug cost solution works through the physician to improve formulary adherence to lower pharmacy costs. Contact us today to help you bridge the gap in healthcare disparities. 

More To Explore

Article

A New Way to Manage the GLP-1 Explosion

GLP-1 receptor agonists are all the rage these days for the promise of easy weight loss. GLP1s are FDA-approved for managing Type 2 diabetes but physicians are prescribing the medication for off-label use to help their patients lose weight. Between 2020 and 2023, the use of GLP-1 medications such as Ozempic and Wegovy, increased sharply due to off-label prescriptions. While these medications are very effective, they are also very expensive, which is challenging insurers, employers, and patients alike. As the demand for GLP-1 drugs continues to grow, particularly for weight loss, understanding the complexities of coverage and finding cost-saving strategies has become a top priority.

Article

The Promise of Precision Medicine

In the U.S., medical treatment is based on the diagnosis, not the person. It’s a one-size-fits-all approach in which physicians prescribe medications that have been approved to treat the disease state. The approach has improved lives for many but not all. Recently, a new approach to pharmacology is developing, precision medicine, which tailors a treatment to an individual’s biology.

Ready to Get Started?

We're Here

To Help You Save

And, we are waiting…
Contact us, and we will be more than happy to answer all of your questions.